In many ways, major Cannabis companies are like pharmaceutical companies. They produce and sell products used for medicinal purposes, and their main pages have statements on how science is the most important thing in their work. We looked at 10 major pharmaceutical companies, and 10 major cannabis companies, and compared what positions they had for scientists, and their R&D spending. Unlike pharmaceutical companies, cannabis companies rarely have any scientists in the executive suites. Further, R&D spending from most of the cannabis companies we looked at was below 5% of their annual income (less than many agricultural companies), indicating these companies are not putting their money where their mouth is.
In this op-ed, Dr. Roggen et al. propose a system for websites like Leafly that would allow its users to share revenue from their content and personal data, enabling a higher sense of trust, credibility and ultimately more value for every stakeholder involved. Using NFTs, they suggest consumers in the cannabis industry could generate a product and benefit from it too